Stock-Based Compensation (Tables) |
9 Months Ended |
|---|---|
Mar. 31, 2026 | |
| Stock-Based Compensation [Abstract] | |
| Summarized Stock Option Activity | Number of shares Weighted average exercise price ($) Weighted average remaining contractual term (in years) Aggregate intrinsic value ($'000) Weighted average grant date fair value ($) Outstanding - June 30, 2025 5,866,904 8.71 3.55 703 1.20 Outstanding - March 31, 2026 5,866,904 8.71 2.55 1,107 1.20 Outstanding - June 30, 2024 4,918,248 8.70 4.51 889 1.77 Granted – December 2024 350,000 6.00 - 433 1.24 Granted – December 2024 250,000 8.00 - 177 0.71 Granted – January 2025 100,000 8.00 2.00 71 0.71 Granted – January 2025 150,000 11.00 2.00 107 0.71 Granted – January 2025 150,000 14.00 2.00 123 0.82 Exercised (36,345) 3.02 - 70 - Forfeited (13,333) 11.23 - - 8.83 Outstanding - March 31, 2025 5,868,570 8.71 3.79 886 1.20 Number of shares Weighted average exercise price ($) Weighted average remaining contractual term (in years) Aggregate intrinsic value ($’000) Vested 5,866,904 8.71 2.55 1,107 Number of shares Weighted average exercise price ($) Weighted average remaining contractual term (in years) Aggregate intrinsic value ($’000) Exercisable - March 31, 2026 866,904 3.99 2.95 1,107 |
| Schedule Of Range Of Assumptions Used To Value Stock Options Granted | Nine months ended March 31, 2025 Expected volatility 42 % Expected dividends 0 % Expected life (in years) 2 Risk-free rate 4.3 % |
| Restricted Stock Activity | Number of shares of restricted stock Weighted average grant date fair value ($’000) Non-vested – June 30, 2025 2,169,900 7,833 Total granted 1,009,095 4,012 Granted – July 2025 3,772 17 Granted – August 2025 5,323 25 Granted – September 2025 200,000 922 Granted – October 2025 215,000 905 Granted – November 2025 160,000 708 Granted – November 2025, with performance conditions 245,000 598 Granted – February 2026 150,000 698 Granted – March 2026 30,000 139 Total vested (238,845) 949 Vested (10,933) 50 Vested (33,333) 139 Vested (120,434) 465 Vested (52,479) 196 Vested (21,666) 99 Forfeitures (361,413) 1,437 Forfeitures (103,545) 475 Forfeitures December 2022 award with market conditions (257,868) 962 Non-vested – March 31, 2026 2,578,737 9,825 Non-vested – June 30, 2024 2,084,946 8,736 Total Granted 1,396,110 5,204 Granted – August 2024 32,800 154 Granted – October 2024 100,000 490 Granted – November 2024, with performance conditions 1,198,310 4,206 Granted – January 2025 65,000 354 Total vested (556,641) 2,865 Vested (78,801) 394 Vested (213,687) 1,134 Vested (103,638) 524 Vested (77,306) 417 Vested (13,922) 68 Vested (69,287) 328 Forfeitures (108,243) 537 Non-vested – March 31, 2025 2,816,172 10,955 |
| Recorded Net Stock Compensation Charge | Total Allocated to cost of goods sold, IT processing, servicing and support Allocated to selling, general and administration Three months ended March 31, 2026 Stock-based compensation charge $ 1,406 $ - $ 1,406 Stock compensation charge related to ESOP 167 - 167 Reversal of stock compensation charge related to restricted stock forfeited (239) - (239) Total - three months $ 1,334 $ - $ 1,334 Three months ended March 31, 2025 Stock-based compensation charge $ 2,531 $ - $ 2,531 Reversal of stock compensation charge related to restricted stock forfeited (34) - (34) Total - three months $ 2,497 $ - $ 2,497 a Total Allocated to cost of goods sold, IT processing, servicing and support Allocated to selling, general and administration Nine months ended March 31, 2026 Stock-based compensation charge $ 4,947 $ - $ 4,947 Stock compensation charge related to ESOP 495 - 495 Reversal of stock compensation charge related to stock forfeited (302) - (302) Total - nine months $ 5,140 $ - $ 5,140 Nine months ended March 31, 2025 Stock-based compensation charge $ 7,563 $ - $ 7,563 Reversal of stock compensation charge related to stock forfeited (45) - (45) Total - nine months $ 7,518 $ - $ 7,518 |